Related Experiment Video
Updated: Feb 5, 2026

Inducing Acute Lung Injury in Mice by Direct Intratracheal Lipopolysaccharide Instillation
Published on: July 6, 2019
[Protective effect of microRNA-155 antisense oligonucleotid on lipopolysaccharide-induced acute lung injury in mice]
Jin Tang1, Wang Xie, Tingting Cheng
1Department of Central ICU, East Hospital, Tongji University School of Medicine, Shanghai 200123, China (Tang J); Department of Respiration, East Hospital, Tongji University School of Medicine, Shanghai 200123, China (Xie W, Cheng TT, Wang KL, Gu X, Zhang Q, Guo ZL). Corresponding author: Guo Zhongliang,
Objective:
To investigate the protective effect of microRNA-155 (miR-155) antisense oligonucleotid (ASO) on acute lung injury (ALI) mice by establishing a lentiviral expression vector of ASO of miRNA.
Methods:
miR-155 antisense oligonucleotides amplified by polymerase chain reaction (PCR) from genomic, using BamH I and Nhe I double digestion, ligated into lentiviral expression vector. Sequence and virus titer were measured. According to the random number table method, 54 male BALB/c mice of 4-6 weeks old were divided into three groups. ALI animal models were prepared by intraperitoneal injection of 10 mg/kg lipopolysaccharide (LPS). The three groups were injected with 200 μL phosphate buffered saline (PBS) containing 1×108/mL pmiR-155-ASO virus (pmiR-155-ASO group) or 200 μL PBS containing 1×108/mL pSMPUW-miR-GFP empty virus (pmiR-cont group) or the same amount of PBS (PBS group) at 24 hours before the molding. Ten mice in each group were used to observe the 7-day survival rate. Blood samples and lung tissues of the remaining 8 mice were harvested after the model was established, and the levels of serum inflammatory cytokines were determined by enzyme linked immunosorbent assay (ELISA); the expression of miR-155 in lung tissue was detected by real-time reverse transcription-polymerase chain reaction (RT-PCR); histopathological changes of lung and distribution of macrophages were observed under microscope.
Results:
There was no significant difference in each index between pmiR-cont group and PBS group. The mature miR-155 expression in lung tissue in pmiR-155-ASO group was significantly lower than that in pmiR-cont group (2-ΔΔCt: 4.92±0.72 vs. 15.38±0.60, P < 0.05). Compared with pmiR-cont group, the injury degree of ALI mice after pretreatment with miR-155 ASO was significantly improved, and the 7-day survival rate was significantly increased (72.1% vs. 61.9%, P < 0.05 ); gross lung observation showed that congestion in lung tissue was significantly reduced, and the ratio of wet/dry weight (W/D) of lung was significantly decreased (4.50±0.13 vs. 5.64±0.61, P < 0.05); hematoxylin-eosin (HE) staining showed that inflammatory cell infiltration in lung tissue was decreased, while immunofluorescence assay showed that macrophage infiltration in lung tissue was significant decreased; the levels of tumor necrosis factor-α (TNF-α) and interleukin-6 (IL-6) in serum were significantly decreased [TNF-α (ng/L): 379.8±48.9 vs. 495.9±33.3, IL-6 (ng/L): 262.3±61.8 vs. 355.4±22.6, both P < 0.05], but the level of IL-10 did not change significantly (ng/L: 143.6±32.5 vs. 140.4±22.3, P > 0.05).
Conclusions:
miR-155 ASO has the effect of inhibiting LPS-induced inflammatory response and improving prognosis in ALI mice.
Insights
MicroRNA-155 antisense oligonucleotides (ASO) protected against acute lung injury (ALI) in mice by reducing inflammation and improving survival rates. This study demonstrates miR-155 ASO as a potential therapeutic for ALI.
Area of Science:
- Molecular Biology
- Immunology
- Pulmonary Medicine
Background:
- Acute lung injury (ALI) is a severe condition with high mortality.
- MicroRNA-155 (miR-155) is implicated in inflammatory responses.
- Targeting miR-155 may offer a therapeutic strategy for ALI.
Purpose of the Study:
- To evaluate the protective effects of miR-155 antisense oligonucleotides (ASO) in a mouse model of ALI.
- To establish a lentiviral expression vector for delivering miR-155 ASO.
Main Methods:
- A lentiviral vector expressing miR-155 ASO was constructed.
- Acute lung injury was induced in BALB/c mice using lipopolysaccharide (LPS).
- Mice were treated with miR-155 ASO, a control virus, or PBS, and outcomes including survival, lung pathology, cytokine levels, and miR-155 expression were assessed.
Main Results:
- miR-155 ASO treatment significantly reduced miR-155 expression in lung tissue.
- Pretreatment with miR-155 ASO improved ALI severity, increased 7-day survival rates, and reduced lung congestion and wet/dry weight ratio.
- Histopathological analysis showed decreased inflammatory and macrophage infiltration in the lungs, with reduced levels of TNF-α and IL-6.
Conclusions:
- miR-155 ASO effectively inhibits lipopolysaccharide-induced inflammatory responses in ALI mice.
- This inhibition leads to improved prognosis and reduced lung injury.
- miR-155 ASO represents a promising therapeutic agent for acute lung injury.
Related Concept Videos
MicroRNAs
MicroRNAs
Acute Kidney Injury I: Introduction
Acute Kidney Injury II: Pathophysiology
Acute Kidney Injury VI: Nursing Management
Acute Kidney Injury V: Interprofessional Care

